Core Viewpoint - BioHarvest Sciences Inc. has approved long-term incentive awards to align employee interests with shareholder value and support growth across its business segments [1][3]. Group 1: Long-term Incentive Awards - The awards include 516,812 stock options and 264,121 restricted share units (RSUs), with stock options valid for 10 years and both options and RSUs vesting quarterly over three years starting March 13, 2026 [2]. - The equity-based incentives are designed to reward and retain top talent while minimizing immediate cash impact on the company [3]. Group 2: Business Strategy and Growth - BioHarvest is focused on expanding its proprietary Botanical Synthesis platform in consumer nutraceutical products and its contract development and manufacturing organization (CDMO) division [4]. - The company emphasizes the importance of attracting and retaining exceptional talent as a key driver of sustainable growth and shareholder returns [4]. Group 3: Company Overview - BioHarvest Sciences Inc. is a leader in Botanical Synthesis, utilizing its patented technology to produce plant-based compounds without growing the underlying plants [5]. - The company aims to develop science-based therapeutic solutions in two major business verticals: as a CDMO and as a creator of proprietary nutraceutical health products [5].